Sarepta Therapeutics, Inc 10-Q for FY2023 Q2
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2023-08-02
For: 2023-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on August 2, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $261.24M
- up 11.9% from $233.49M a year earlier
- Net loss
- $23.94M
- compared with a net loss of $231.48M a year earlier
- Diluted EPS
- -$0.27
- compared with -$2.65 a year earlier